Start free

Madrigal Pharmaceuticals, Inc. (MDGL) insider trading

Recent insider transactions reported to the SEC on Form 4 — directors and officers buying or selling their own company’s stock. Sourced directly from public SEC filings, latest filed Nov 6, 2026.

Filings shown
15
Open-market buys
5
Open-market sells
50
Buys, 10b5-1 box not checked
5 of 5

Counts cover the 15 most recent Form 4 filings Tradune holds for MDGL (filed May 18 – Nov 6, 2026); the score below covers only the trailing 90 days (5 buys, 25 sells). SEC EDGAR Form 4 filings for MDGL last checked Nov 21, 2026, 09:00 UTC; the latest MDGL filing Tradune holds was filed Nov 6, 2026. This is not guaranteed to be the complete record — see MDGL's full Form 4 filing history on SEC EDGAR.

Open-market activity, last 90 days

Purchases (Form 4 code P) and sales (code S) on the 3 filings Tradune holds for MDGL filed Sep 11 – Nov 6, 2026. Grants, exercises, tax withholding and the other Form 4 transaction codes are left out.

25 open-market sales by Rule 10b5-1 checkbox

On filings with the 10b5-1 box checked
25 sales· 12,660 sh
checkbox disclosed
On filings with the box not checked
0 sales· 0 sh
not proof that no plan exists
Not comparable
0 sales· 0 sh
filed before Apr 1, 2023, or no checkbox value in the filing data

Counts are Form 4 lines as filed. The checkbox is one per filing, so every sale on a filing with the box checked is counted there even if only some of its transactions were under a plan; it records what the filer disclosed, and the three categories are not a judgement about why a sale was made.

Open-market purchases and sales by insider
Insider Buys Sells Shares bought Shares sold Value
William John SiboldPresident and CEO 0 24 — 11,583 −$6,239,198
Baker Bros. Advisors LPDirector 5 0 91,806 — +$35,023,032
Shannon T. KelleyGeneral Counsel 0 1 — 1,077 −$430,800

Value = shares × the price reported on each Form 4 (+ purchases, − sales); every open-market line in this window disclosed a price.

Insider-activity score

56/ 100

Net insider purchases
1 distinct buyer5 buy · 25 sell txofficer buying

Summarises ~90 days of public SEC Form 4 activity — more distinct buyers, officer involvement and net buying score higher. A description of filing activity, not a rating or buy signal. How this score is computed →

Get alerted when insiders buy the stocks you own

Add your holdings — no brokerage login — and Insider Radar sends a Telegram alert when an open-market Form 4 buy of $100,000 or more is filed on a stock you hold or watch.

Free for everyone right now · no card · nothing to buy

Start free

How to read this: an open-market purchase (Form 4 code P) is a buy at the market price with the insider’s own money, as opposed to a grant, award or option exercise; an open-market sale is code S. When two or more distinct insiders report open-market purchases in the same 90-day window, this site labels that a cluster — a definition, not a forecast; see insider cluster buying. “Held after” is Form 4 Table I column 5; “Change” = shares ÷ holdings before the trade (held after − shares for an acquisition, held after + shares for a disposition).

Insider Buying at MDGL

Insiders reported 5 open-market purchases of MDGL between May 18, 2026 and Nov 6, 2026, across 1 distinct buyer. The most recent purchase was reported by Baker Bros. Advisors LP (Director) on Nov 6, 2026. Grants, option exercises, and tax-withholding transactions are excluded from these counts.

Recent Form 4 filings

Source: SEC EDGAR Form 4 · transaction codes explained

Shannon T. Kelley General Counsel · filed Nov 6, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Open-market sale 10b5-1 box checked 1,077 $400.00 10,397 −9.4% Nov 6, 2026

† change in this filer’s own reported holding line (Form 4 Table I, col. 5), not of total company ownership; small prior holdings produce large percentages, so under 100 shares the prior holding is shown instead.

“10b5-1 box checked” = the filer checked the Form 4 box stating that a transaction on the filing was made under a plan intended to satisfy Rule 10b5-1(c); “10b5-1 box not checked” = the box was left blank, which does not prove that no plan exists. The box applies to Form 4s filed from April 1, 2023; older filings, and boxes we could not read, carry no tag. What the 10b5-1 box means.

Baker Bros. Advisors LP Director · filed Nov 6, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Open-market purchase 10b5-1 box not checked 13,740 $388.29 2,038,682 (indirect) +0.7% Nov 6, 2026
Open-market purchase 10b5-1 box not checked 2,000 $396.61 2,040,682 (indirect) +0.1% Nov 6, 2026
Open-market purchase 10b5-1 box not checked 60,400 $383.02 2,024,942 (indirect) +3.1% Nov 6, 2026
Open-market purchase 10b5-1 box not checked 5,586 $366.99 1,954,462 (indirect) +0.3% Nov 4, 2026
Open-market purchase 10b5-1 box not checked 10,080 $368.11 1,964,542 (indirect) +0.5% Nov 4, 2026
William John Sibold President and CEO · filed Sep 11, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Open-market sale 10b5-1 box checked 368 $541.64 201,368 −0.2% Sep 11, 2026
Open-market sale 10b5-1 box checked 1,202 $542.60 200,166 −0.6% Sep 11, 2026
Open-market sale 10b5-1 box checked 1,539 $544.02 198,627 −0.8% Sep 11, 2026
Open-market sale 10b5-1 box checked 761 $544.83 197,866 −0.4% Sep 11, 2026
Open-market sale 10b5-1 box checked 120 $546.38 197,746 −0.1% Sep 11, 2026
Open-market sale 10b5-1 box checked 60 $533.09 202,907 −0.0% Sep 11, 2026
Open-market sale 10b5-1 box checked 106 $534.06 202,801 −0.1% Sep 11, 2026
Open-market sale 10b5-1 box checked 218 $535.94 202,583 −0.1% Sep 11, 2026
Open-market sale 10b5-1 box checked 160 $537.62 202,423 −0.1% Sep 11, 2026
Open-market sale 10b5-1 box checked 687 $540.59 201,736 −0.3% Sep 11, 2026
Open-market sale 10b5-1 box checked 640 $537.17 204,729 −0.3% Sep 9, 2026
Open-market sale 10b5-1 box checked 131 $527.88 209,198 −0.1% Sep 9, 2026
Open-market sale 10b5-1 box checked 347 $529.27 208,851 −0.2% Sep 9, 2026
Open-market sale 10b5-1 box checked 522 $530.23 208,329 −0.2% Sep 9, 2026
Open-market sale 10b5-1 box checked 368 $531.99 207,961 −0.2% Sep 9, 2026
Open-market sale 10b5-1 box checked 512 $533.09 207,449 −0.2% Sep 9, 2026
Open-market sale 10b5-1 box checked 396 $534.20 207,053 −0.2% Sep 9, 2026
Open-market sale 10b5-1 box checked 644 $535.27 206,409 −0.3% Sep 9, 2026
Open-market sale 10b5-1 box checked 1,040 $536.11 205,369 −0.5% Sep 9, 2026
Open-market sale 10b5-1 box checked 520 $538.30 204,209 −0.3% Sep 9, 2026
Open-market sale 10b5-1 box checked 215 $539.03 203,994 −0.1% Sep 9, 2026
Open-market sale 10b5-1 box checked 505 $540.19 203,489 −0.2% Sep 9, 2026
Open-market sale 10b5-1 box checked 362 $541.65 203,127 −0.2% Sep 9, 2026
Open-market sale 10b5-1 box checked 160 $542.55 202,967 −0.1% Sep 9, 2026
Shannon T. Kelley General Counsel · filed Aug 20, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Open-market sale 10b5-1 box not checked 664 $514.97 11,474 −5.5% Aug 17, 2026
John C. Reed Director · filed Aug 18, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Grant / award Stock Option (Right to Buy) 1,078 — — — Aug 15, 2026
Grant / award 647 — 647 — Aug 15, 2026
William John Sibold President and CEO · filed Jul 20, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Open-market sale 10b5-1 box not checked 269 $547.08 210,490 −0.1% Jul 20, 2026
Open-market sale 10b5-1 box not checked 140 $542.75 211,689 −0.1% Jul 20, 2026
Open-market sale 10b5-1 box not checked 110 $543.79 211,579 −0.1% Jul 20, 2026
Open-market sale 10b5-1 box not checked 545 $544.71 211,034 −0.3% Jul 20, 2026
Open-market sale 10b5-1 box not checked 275 $545.71 210,759 −0.1% Jul 20, 2026
Open-market sale 10b5-1 box not checked 680 $547.70 209,810 −0.3% Jul 20, 2026
Open-market sale 10b5-1 box not checked 47 $548.87 209,763 −0.0% Jul 20, 2026
Open-market sale 10b5-1 box not checked 153 $550.01 209,610 −0.1% Jul 20, 2026
Open-market sale 10b5-1 box not checked 1 $550.72 209,609 −0.0% Jul 20, 2026
Open-market sale 10b5-1 box not checked 280 $555.05 209,329 −0.1% Jul 20, 2026
Option exercise Performance Restricted Stock Units 50,000 — — — Jul 17, 2026
Option exercise 50,000 — 211,829 +31% Jul 17, 2026
Rebecca Taub Director · filed Jun 18, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Grant / award 454 — 452,667 +0.1% Jun 17, 2026
Grant / award Stock Option (Right to Buy) 766 — — — Jun 17, 2026
Richard S. Levy Director · filed Jun 18, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Grant / award 454 — 22,469 +2.1% Jun 17, 2026
Grant / award Stock Option (Right to Buy) 766 — — — Jun 17, 2026
Jacqualyn A. Fouse Director · filed Jun 18, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Grant / award 454 — 1,551 +41% Jun 17, 2026
Grant / award Stock Option (Right to Buy) 766 — — — Jun 17, 2026
James M. Daly Director · filed Jun 18, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Grant / award 454 — 3,081 +17% Jun 17, 2026
Grant / award Stock Option (Right to Buy) 766 — — — Jun 17, 2026
Daniel J. Brennan Director · filed Jun 18, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Grant / award 404 — 1,371 +42% Jun 17, 2026
Grant / award Stock Option (Right to Buy) 681 — — — Jun 17, 2026
Baker Bros. Advisors LP Director · filed Jun 18, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Grant / award 908 — 1,948,876 (indirect) +0.0% Jun 17, 2026
Grant / award Non-Qualified Stock Options (right to buy) 1,532 — — — Jun 17, 2026
Grant / award Non-Qualified Stock Options (right to buy) 1,532 — — — Jun 17, 2026
Grant / award 908 — 203,721 (indirect) +0.4% Jun 17, 2026
David Soergel Chief Medical Officer · filed Jun 1, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Open-market sale 10b5-1 box checked 1,042 $495.74 10,033 −9.4% Jun 1, 2026
Richard S. Levy Director · filed May 22, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Open-market sale 10b5-1 box checked 80 $519.98 22,015 −0.4% May 22, 2026
Open-market sale 10b5-1 box checked 151 $510.36 27,186 −0.6% May 22, 2026
Open-market sale 10b5-1 box checked 320 $508.24 27,337 −1.2% May 22, 2026
Open-market sale 10b5-1 box checked 40 $506.68 27,657 −0.1% May 22, 2026
Open-market sale 10b5-1 box checked 610 $511.40 26,576 −2.2% May 22, 2026
Open-market sale 10b5-1 box checked 439 $512.50 26,137 −1.7% May 22, 2026
Open-market sale 10b5-1 box checked 40 $512.97 26,097 −0.2% May 22, 2026
Open-market sale 10b5-1 box checked 343 $514.67 25,754 −1.3% May 22, 2026
Open-market sale 10b5-1 box checked 657 $515.92 25,097 −2.6% May 22, 2026
Open-market sale 10b5-1 box checked 723 $516.87 24,374 −2.9% May 22, 2026
Open-market sale 10b5-1 box checked 1,497 $517.59 22,877 −6.1% May 22, 2026
Open-market sale 10b5-1 box checked 782 $518.76 22,095 −3.4% May 22, 2026
David Soergel Chief Medical Officer · filed May 18, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Open-market sale 10b5-1 box not checked 844 $515.90 11,075 −7.1% May 18, 2026

Insider filings reported around the same time

Other companies whose most recent Form 4 was filed closest to MDGL's (Nov 6, 2026).

Frequently asked about MDGL insider activity

How many insiders bought MDGL stock in these Form 4 filings?

1 distinct insider at Madrigal Pharmaceuticals, Inc. reported 5 open-market purchases (Form 4 code P) of MDGL shares between May 18, 2026 and Nov 6, 2026, the most recent filed by Baker Bros. Advisors LP (Director) on Nov 6, 2026. Grants, option exercises, and tax-withholding transactions are excluded from these counts.

Who filed the most recent Form 4 for MDGL?

The most recent Form 4 on this page was filed by Baker Bros. Advisors LP (Director) on Nov 6, 2026, reporting 5 transactions. The original document is linked from the filing list above on SEC EDGAR. Amended filings (Form 4/A) may later revise reported figures.

What was the largest open-market MDGL insider purchase shown?

The largest open-market purchase among the filings shown was 60,400 MDGL shares at $383.02 (about $23,134,106) by Baker Bros. Advisors LP (Director) on Nov 6, 2026. Value is shares × the price reported on the Form 4; its Rule 10b5-1 box is not checked.

Do the recent MDGL insider purchases have the Form 4 10b5-1 box checked?

No. All 5 MDGL open-market purchases shown were reported with the Rule 10b5-1 box not checked. A blank box records what the filer disclosed; it does not prove that no plan exists. Latest: Baker Bros. Advisors LP (Director) on Nov 6, 2026, 60,400 shares.

New to Form 4s? The transaction codes, the 90-day window and the 0–100 score are defined on the insider-activity score methodology page.

Get insider alerts for MDGL — and your whole portfolio

Tradune watches SEC Form 4 filings and flags insider-cluster buying across everything you hold, routed to you automatically. Free for everyone right now · no card · nothing to buy

This score summarizes SEC Form 4 filing activity over the trailing 90 days. It is descriptive, not predictive — not a rating, recommendation, or investment advice. Data: SEC EDGAR (public domain), as filed; amendments may revise figures. Tradune is not a registered investment adviser.

Data as filed; amended filings (Form 4/A) may revise figures. Sales may occur under prearranged Rule 10b5-1 trading plans.